Axonis Therapeutics | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Axonis Therapeutics is a Boston-based biotechnology company focused on developing innovative medicines for neurological disorders.
Industry & Market
Funding Information
Headcount Distribution
By Department
Department Breakdown
Keywords & Focus Areas
Overview
Axonis Therapeutics is a Boston-based biotechnology company focused on developing innovative medicines for neurological disorders. The company specializes in targeting KCC2, a key mediator of inhibitory neurotransmission in the brain. Its mission is to restore functional inhibition in the central nervous system to address conditions like epilepsy and chronic pain, where existing therapies often fall short.
Founded on scientific discoveries from Boston Children’s Hospital, Harvard University, and Laval University, the organization utilizes a proprietary KCC2 discovery engine to create oral KCC2 potentiator drugs. Its lead candidate, AXN-027, is currently in first-in-human clinical trials and aims to improve treatment outcomes for patients by overcoming impaired synaptic inhibition. The company has secured substantial financial support, including a $115 million Series A financing round in October 2024, reflecting strong investor confidence in its technology and pipeline. It is committed to providing new treatment options for patients suffering from neurological disorders, particularly those with epilepsy and chronic pain.
Key Metrics
Get Complete Company Metrics
Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.
Contact
Technology Stack
Analytics & Tracking
Social & Marketing
Database & Backend
Cloud & Infrastructure
Productivity
Compare similar companies to Axonis Therapeutics
Compare insights from companies similar to Axonis Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
| Company Name | Revenue | No. of Employees | Type | Funding | Founded In | Top Executive |
|---|---|---|---|---|---|---|
| xxxxxxxx | $51877 | 57 | Private | - | 3007 | xxxxxxxx |
| xxxx | $55029 | 88 | Private | - | 6725 | xxxxxxxxxx |
| x | $23711 | 28 | Private | - | 6450 | xxxxxxxx |
| xxxxxxx | $6319 | 148 | Private | - | 867 | xxxxxxxx |
| xxxx | $86905 | 82 | Private | - | 5340 | xxxxxx |
Discover Similar Companies Instantly
Explore detailed insights and analysis on companies related to your search.